196 related articles for article (PubMed ID: 32515970)
1. New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve
Almeida Furquim de Camargo B; Soares Silva DE; Noronha da Silva A; Campos DL; Machado Ribeiro TR; Mieli MJ; Borges Teixeira Zanatta M; Bento da Silva P; Pavan FR; Gallina Moreira C; Resende FA; Menegário AA; Chorilli M; Vieira de Godoy Netto A; Bauab TM
Mol Pharm; 2020 Jul; 17(7):2287-2298. PubMed ID: 32515970
[No Abstract] [Full Text] [Related]
2. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
3. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro.
Cai J; Huang H; Song W; Hu H; Chen J; Zhang L; Li P; Wu R; Wu C
Int J Pharm; 2015 Nov; 495(2):728-37. PubMed ID: 26417849
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of nimbolide against Helicobacter pylori.
Wylie MR; Windham IH; Blum FC; Wu H; Merrell DS
J Ethnopharmacol; 2022 Mar; 285():114828. PubMed ID: 34763046
[TBL] [Abstract][Full Text] [Related]
5. Influence of N-acylhomoserine lactonase silver nanoparticles on the quorum sensing system of Helicobacter pylori: A potential strategy to combat biofilm formation.
Gopalakrishnan V; Masanam E; Ramkumar VS; Baskaraligam V; Selvaraj G
J Basic Microbiol; 2020 Mar; 60(3):207-215. PubMed ID: 31960983
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.
Hathroubi S; Servetas SL; Windham I; Merrell DS; Ottemann KM
Microbiol Mol Biol Rev; 2018 Jun; 82(2):. PubMed ID: 29743338
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of Phx-3 against Helicobacter pylori.
Hanawa T; Osaki T; Manzoku T; Fukuda M; Kawakami H; Tomoda A; Kamiya S
Biol Pharm Bull; 2010; 33(2):188-91. PubMed ID: 20118538
[TBL] [Abstract][Full Text] [Related]
8. Rubropunctatin-silver composite nanoliposomes for eradicating Helicobacter pylori in vitro and in vivo.
Zhao L; Liao W; Lin G; Yang J; Shi X; Zheng Y
Int J Pharm; 2024 Jan; 649():123655. PubMed ID: 38043750
[TBL] [Abstract][Full Text] [Related]
9. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of
de Souza MPC; de Camargo BAF; Spósito L; Fortunato GC; Carvalho GC; Marena GD; Meneguin AB; Bauab TM; Chorilli M
Crit Rev Microbiol; 2021 Aug; 47(4):435-460. PubMed ID: 33725462
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
Seabra CL; Nunes C; Gomez-Lazaro M; Correia M; Machado JC; Gonçalves IC; Reis CA; Reis S; Martins MCL
Int J Pharm; 2017 Mar; 519(1-2):128-137. PubMed ID: 28088639
[TBL] [Abstract][Full Text] [Related]
11. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori.
Safarov T; Kiran B; Bagirova M; Allahverdiyev AM; Abamor ES
Expert Rev Anti Infect Ther; 2019 Oct; 17(10):829-840. PubMed ID: 31591930
[No Abstract] [Full Text] [Related]
12. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
Li P; Chen X; Shen Y; Li H; Zou Y; Yuan G; Hu P; Hu H
J Control Release; 2019 Apr; 300():52-63. PubMed ID: 30825476
[TBL] [Abstract][Full Text] [Related]
13. Anti-Helicobacter pylori Activity of Isocoumarin Paepalantine: Morphological and Molecular Docking Analysis.
Damasceno JPL; Rodrigues RP; Gonçalves RCR; Kitagawa RR
Molecules; 2017 May; 22(5):. PubMed ID: 28498343
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori.
Abdelghany A; El-Desouky MA; Shemis M
Arab J Gastroenterol; 2021 Dec; 22(4):278-284. PubMed ID: 34509390
[TBL] [Abstract][Full Text] [Related]
15. Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.
Zhang F; Smolen JA; Zhang S; Li R; Shah PN; Cho S; Wang H; Raymond JE; Cannon CL; Wooley KL
Nanoscale; 2015 Feb; 7(6):2265-70. PubMed ID: 25573163
[TBL] [Abstract][Full Text] [Related]
16. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
17. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
[TBL] [Abstract][Full Text] [Related]
18. A pH-Responsive Persistent Luminescence Nanozyme for Selective Imaging and Killing of
Yan LX; Wang BB; Zhao X; Chen LJ; Yan XP
ACS Appl Mater Interfaces; 2021 Dec; 13(51):60955-60965. PubMed ID: 34904434
[No Abstract] [Full Text] [Related]
19.
Xu YF; Lian DW; Chen YQ; Cai YF; Zheng YF; Fan PL; Ren WK; Fu LJ; Li YC; Xie JH; Cao HY; Tan B; Su ZR; Huang P
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320722
[TBL] [Abstract][Full Text] [Related]
20.
Huang Y; Hang X; Jiang X; Zeng L; Jia J; Xie Y; Li F; Bi H
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
